Kliininen tutkimuskeskus
Clinical Research Center

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Akbar F et al. Haplotypic association of DDAH2 with susceptibility to pre-eclampsia.
2 Boccardi M et al. Frontotemporal dementia as a neural system disease.
3 Bresciani L et al. Visual assessment of medial temporal atrophy on MR films in Alzheimer´s disease: comparison with volumetry.
4 Chaudhuri JD et al. Localization of M2 muscarinic receptor protein in parvalbumin and calretinin containing cells of the adult rat entorhinal cortex using two complementary methods.
5 Cheng S et al. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial.
6 Cheng S et al. Differences in estimates of change of bone accrual and body composition in children because of scan mode selection with the prodigy densitometer.
7 Dahlman I et al. The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects.
8 De Laet C et al. Body mass index as a predictor of fracture risk: A meta-analysis.
9 Frey HJ et al. Problems associated with biological markers of Alzheimer´s Disease.
10 Frisconi GB et al. Structural correlates of early and late onset Alzheimer`s disease: voxel based morphometric study .
11 González-Sánchez JL et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance.
12 Hakulinen MA et al. Prediction of density and mechanical properties of human trabecular bone in vitro by using ultrasound transmission and backscattering measurements at 0.2-6.7 MHz frequency range.
13 Herukka S-K et al. CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.
14 Huopio J et al. Role of chronic health disorders in perimenopausal fractures.
15 Iivonen S. Genetic and Expressional Studies of Alzheimer´s Disease Candidate Genes.
16 Iqbal K et al. Subgroups of Alzheimer´s disease based on cerebrospinal fluid molecular markers.
17 Jakkula E et al. The role of sequence variations within the genes encoding collagen II, IX and XI in non-syndromic, early-onset osteoarthritis.
18 Johnell O et al. Predictive value of BMD for hip and other fractures.
19 Jones R et al. Response to letter by Bullock and Truyen.
20 Kanis JA et al. Smoking and fracture risk: a meta-analysis.
21 Kettunen J, Kröger H. Surgical treatment of ankle and foot fractures in the elderly.
22 Kivipelto M et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer´s disease.
23 Koistinen A et al. Effect of bone mineral density and amourphous diamond coatings on insertion torque of bone screws.
24 Korolainen MA et al. Proteomic analysis of glial fibrillary acidic protein in Alzheimer´s disease and aging brain.
25 Kröger H. Osteoporoosin diagnostiikka - laitteilla vai ilman?
26 Kärkkäinen T et al. Lonkan uudelleenmurtuman esiintyvyys Kuopion yliopistollisessa sairaalassa vuosina 1999-2000.
27 Kärkkäinen T et al. Lonkan uudelleenmurtuman esiintyvyys Kuopion yliopistollisessa sairaalassa vuosina 1999-2000.
28 Laukkanen O et al. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversation from impaired glucose tolerance to type 2 diabetes.The Finnish diabetes prevention study.
29 Li X et al. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alxheimer's disease brain.
30 Mehta PD, Pirttila T. Increased cerebrospinal fluid Abeta38/Abeta42 ration in Alzheimer Disease.
31 Miettinen R et al. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
32 Mousavinasab F et al. Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men.
33 Mousavinasab F et al. Effect of the Pro12Ala polymorphism of the PPARgamma2 gene on serum adiponectin changes.
34 Mursu J et al. Polyphenol-rich phloem enhances the resistance of total serum lipids to oxidation in men.
35 Peltola P et al. Genetics and phenotypic characteristics of autosomal dominant polycystic kidney disease in Finns.
36 Pennanen C et al. A voxel based morphometry study on mild cognitive impairment.
37 Pesonen J et al. High bone mineral density among perimenopausal women.
38 Pihlajamäki J et al. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offpring of patients with type 2 diabetes.
39 Pihlajamäki M et al. Distinct and overlapping fMRI activation networks for processing of novel identities and locations of objects.
40 Pirskanen M et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer´s disease in women.
41 Salmenniemi U et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients.
42 Salopuro T et al. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish diabetes prevention study.
43 Sandini L et al. Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
44 Sipola P et al. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.
45 Sirola J, Rikkonen T. Muscle performance after the menopause.
46 Sirola J et al. Associations between grip strength change and axial postmenopausal bone loss-a 10-year population-based follow-up study .
47 Soininen H, Pirttilä T. Onko Alzheimer-lääkkeistä hyötyä?
48 Soininen H. Muistihäiriöiden varhaisdiagnostiikka kaipaa tehostamista.
49 Soininen H et al. Can mild cognitive impairment predict Alzheimer´s disease?
50 Vepsäläinen S et al. Genetic analysis on BDNF and TrkB gene polymorphisms in Alzheimer´s disease.
51 Vänttinen M et al. Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.
52 Vänttinen M et al. The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.
53 Yang X et al. Effect of the interleukin-6 (-174) G/C promoter polymorphism on adiponectin and insulin sensitivity.
54 Zacharova J et al. Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance.
55 Zacharova J et al. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOPP-NIDDM trial.
56 Zacharova J et al. The G-250A substitution in the promoter region of the hepatic lipase gene is associated with the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Kliininen tutkimuskeskus Clinical Research Center
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008